Non-carboxylic antiinflammatory compounds. III. N-(4,6-Dimethylpyridin-2-yl)arylcarboxamides and arylthiocarboxamides acting as brain edema inhibitors
摘要:
Pharmacomodulation of the non-carboxylic NSAID N-(4,6-dimethylpyridin-2-yl)benzamide 1 led to the synthesis of structurally related furan, thiophene and pyrrole carboxamides 3-14. The derivatives benzenethiocarboxamides 15-18 and heteroaryl-thiocarboxamides 19-22 were also prepared by oxygen/sulfur exchange; this reaction was more efficiently carried out by P4S10 than by Lawesson's reagent. The 20 synthesized compounds were evaluated against peripheral edema by a foot-pad carrageenin-induced edema test. Amides 3-5, 8, 9, 11, 12 and 14 were most active, exhibiting > 90% inhibition after oral administration of 0.8 mmol . kg(-1). Two amides, 3 and 5, were selected for evaluation of their inhibitory activity in PLA(2)-induced brain edema and were found to be more potent than dexamethasone after LP administration.
Non-carboxylic antiinflammatory compounds. III. N-(4,6-Dimethylpyridin-2-yl)arylcarboxamides and arylthiocarboxamides acting as brain edema inhibitors
摘要:
Pharmacomodulation of the non-carboxylic NSAID N-(4,6-dimethylpyridin-2-yl)benzamide 1 led to the synthesis of structurally related furan, thiophene and pyrrole carboxamides 3-14. The derivatives benzenethiocarboxamides 15-18 and heteroaryl-thiocarboxamides 19-22 were also prepared by oxygen/sulfur exchange; this reaction was more efficiently carried out by P4S10 than by Lawesson's reagent. The 20 synthesized compounds were evaluated against peripheral edema by a foot-pad carrageenin-induced edema test. Amides 3-5, 8, 9, 11, 12 and 14 were most active, exhibiting > 90% inhibition after oral administration of 0.8 mmol . kg(-1). Two amides, 3 and 5, were selected for evaluation of their inhibitory activity in PLA(2)-induced brain edema and were found to be more potent than dexamethasone after LP administration.
Pharmaceutical combinations comprising at least one mTOR inhibitor and their uses in treating arthritis or rheumatic arthritis and disorders associated therewith.
Pharmaceutical combinations comprising at least one mTOR inhibitor and their uses in treating arthritis or rheumatic arthritis and disorders associated therewith.
Non-carboxylic antiinflammatory compounds. III. N-(4,6-Dimethylpyridin-2-yl)arylcarboxamides and arylthiocarboxamides acting as brain edema inhibitors
作者:J.M.H. Robert、S Robert-Piessard、J Courant、G Le Baut、B Robert、F Lang、J.Y. Petit、N Grimaud、L Welin
DOI:10.1016/0223-5234(96)88310-3
日期:1995.1
Pharmacomodulation of the non-carboxylic NSAID N-(4,6-dimethylpyridin-2-yl)benzamide 1 led to the synthesis of structurally related furan, thiophene and pyrrole carboxamides 3-14. The derivatives benzenethiocarboxamides 15-18 and heteroaryl-thiocarboxamides 19-22 were also prepared by oxygen/sulfur exchange; this reaction was more efficiently carried out by P4S10 than by Lawesson's reagent. The 20 synthesized compounds were evaluated against peripheral edema by a foot-pad carrageenin-induced edema test. Amides 3-5, 8, 9, 11, 12 and 14 were most active, exhibiting > 90% inhibition after oral administration of 0.8 mmol . kg(-1). Two amides, 3 and 5, were selected for evaluation of their inhibitory activity in PLA(2)-induced brain edema and were found to be more potent than dexamethasone after LP administration.